Search This Blog

Monday, August 3, 2026

B. Riley raises Anika Therapeutics price target to $21 from $18, reiterates Buy

 

B. Riley raises Anika Therapeutics price target to $21 from $18, reiterates Buy after stronger-than-expected Q2 and higher 2026 outlook

  • B. Riley cites improved margins, commercial growth and structural cost improvements as key drivers behind its updated ANIK valuation.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)